A patient started on a high-potency antipsychotic yesterday suddenly develops a stiff, twisted neck and his eyes roll upward and stay there. Which movement disorder is this, and what class of medication treats it?
Choose an answer, then check it.
Clinical Pharmacology · Antipsychotics and Mood Stabilizers
Movement Disorder Adverse Effects
On this page 6 sections
In 30 seconds
Drugs that block dopamine receptors can disrupt the brain's movement-control circuits, producing extrapyramidal symptoms (EPS) that unfold in a fairly predictable order: acute dystonia within hours to days, akathisia within days to weeks, drug-induced parkinsonism within weeks, and tardive dyskinesia only after months to years. A separate emergency, neuroleptic malignant syndrome, can strike at any point and is fatal if missed. Knowing which pattern is which changes the treatment and can save a life.
The college version
Antipsychotics work mainly by blocking dopamine D2 receptors. Blockade in the mesolimbic pathway reduces hallucinations and delusions, but the same blockade in the nigrostriatal pathway — the circuit fine-tuning voluntary movement — produces the disorders below. High-potency first-generation agents (like haloperidol) carry the highest EPS risk. Second-generation agents cause less EPS overall, often because they also block serotonin 5-HT2A receptors, restoring some striatal dopamine tone, but none is entirely risk-free; clozapine and quetiapine carry the lowest.
Acute Dystonia
The earliest and most alarming reaction, appearing within hours to days of starting or increasing a dopamine blocker. Sudden, sustained involuntary contractions twist the neck (torticollis), arch the back, or force the eyes upward and locked (oculogyric crisis). The most dangerous form involves the throat — laryngospasm — a true emergency. Treatment is an anticholinergic (benztropine) or an antihistamine with anticholinergic properties (diphenhydramine), which restores the dopamine-acetylcholine balance in the striatum.
Akathisia
Usually emerges within days to weeks. It is a subjective, intensely uncomfortable inner restlessness driving constant movement — pacing, rocking, an inability to sit still. Patients often describe it as anxiety or worsening psychiatric illness rather than a movement problem, so it is frequently mistaken for the underlying condition; raising the antipsychotic dose in response actually worsens it. Management includes dose reduction, switching to a lower-EPS agent, or adding a beta blocker (classically propranolol); benzodiazepines are also used. Distinguishing it from anxiety matters, since the correct responses differ.
Drug-Induced Parkinsonism
Develops over days to weeks and mimics idiopathic Parkinson disease because it arises from the same dopamine-deficient state, just chemically induced. Features include bradykinesia, cogwheel rigidity, resting tremor, a shuffling gait, and masked facies (a flat, unexpressive face). It is typically symmetric, unlike idiopathic Parkinson disease. Management is dose reduction, switching agents, or adding an anticholinergic; symptoms are generally reversible.
Tardive Dyskinesia
The late, potentially permanent member of this family, developing only after months to years of cumulative dopamine blockade, as the striatum becomes supersensitive to dopamine. It produces repetitive, involuntary choreoathetoid (writhing, dance-like) movements, classically of the face and tongue — lip smacking, tongue thrusting, grimacing — though trunk and limbs can be involved. Unlike earlier EPS, stopping the antipsychotic does not reliably reverse it and can transiently worsen it. VMAT2 inhibitors are the only agents specifically approved to treat it; they reduce dopamine packaged into synaptic vesicles, calming abnormal movements without re-blocking the receptor. Prevention matters more than treatment here, so routine screening is essential.
Monitoring: The Abnormal Involuntary Movement Scale
The Abnormal Involuntary Movement Scale (AIMS) is a standardized bedside exam used to detect and track tardive dyskinesia over time. The examiner observes the face, mouth, trunk, and limbs at rest and during brief activation movements, rating the severity of any abnormal movement. Baseline AIMS assessment before starting long-term antipsychotic therapy, with periodic reassessment, allows early detection while intervention is still likely to help.
Not Just Antipsychotics
Any dopamine-blocking drug can cause this entire spectrum, not just antipsychotics. Metoclopramide (an antiemetic and prokinetic) and promethazine (an antiemetic and antihistamine) both have meaningful dopamine-blocking activity and are well-documented causes of acute dystonia, akathisia, parkinsonism, and even tardive dyskinesia with prolonged use.
Neuroleptic Malignant Syndrome
Neuroleptic malignant syndrome (NMS) is a rare, life-threatening emergency tied to dopamine blockers, distinct from EPS because it is a systemic crisis rather than a pure movement disorder. Hallmarks are fever, severe "lead-pipe" rigidity, autonomic instability (unstable blood pressure, rapid heart rate, profuse sweating), altered mental status, and markedly elevated creatine kinase reflecting muscle breakdown. Management centers on immediately stopping the causative drug, supportive care including aggressive cooling and fluids, and dantrolene (a direct skeletal muscle relaxant) plus dopamine agonists such as bromocriptine. NMS is often confused with serotonin syndrome, a similarly dangerous reaction from excess serotonergic activity, but the two differ in tempo and exam findings: serotonin syndrome develops rapidly, within hours, with hyperreflexia and clonus, whereas NMS develops more gradually, over days, with rigidity rather than clonus. Telling them apart matters because treatment diverges.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Think of dopamine as a tiny traffic controller that keeps muscles moving smoothly — not too much, not too little, not too jerky. Antipsychotics turn down dopamine to quiet scary thoughts, but they accidentally turn down the traffic-controller part too, so movements can go haywire in different ways depending on how long the medicine has been on board.
Right away, muscles can lock up like a puppet whose strings got pulled too tight — that's dystonia, and if it grabs the throat it's an emergency. Within a couple of weeks, some people get an itchy, can't-sit-still feeling, like ants in their legs — that's akathisia, often mistaken for just being nervous. After a few weeks, some people move stiffly and slowly with a shaky hand and a blank face, like a wind-up toy running low on batteries — that's drug-induced parkinsonism. After months or years, some people develop face and tongue movements they can't control, like invisible strings twitching their mouth — that's tardive dyskinesia, and it can stick around after the medicine stops, so doctors use a checklist called the AIMS exam to catch it early. Separately, a rare, very dangerous reaction called neuroleptic malignant syndrome can make the whole body seize up with fever and stiffness, like an overheating engine that needs shutting off right away.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A nurse monitoring a patient on an antipsychotic for several years notices new lip smacking and tongue thrusting at a routine visit. What tool should have been used periodically to catch this earlier, and what drug class treats it once it appears?
Show answer
The Abnormal Involuntary Movement Scale (AIMS); VMAT2 inhibitors
AIMS is a simple, repeatable checklist used periodically to spot early abnormal movements of the face, mouth, and body before they become obvious, so catching this here means screening was skipped or too infrequent. Once tardive dyskinesia appears, VMAT2 inhibitors are the approved medicines that calm the movements by reducing dopamine release.
A patient in the emergency department who takes promethazine regularly for nausea develops a sudden stiff neck and jaw. Explain why this happens even though promethazine is not an antipsychotic.
Show answer
Promethazine also blocks dopamine receptors, so it can trigger the same movement problems as antipsychotics
Even though promethazine treats nausea and allergies rather than psychosis, it shares the same dopamine-blocking action in the brain, so it can cause acute dystonia just like a high-potency antipsychotic, soon after a dose.
Quick check
3 questions here. Answers stay hidden until you check.
A patient on an antipsychotic reports feeling like she "can't stop moving" and paces constantly, and the team is considering raising her dose because they think her psychosis is worsening. What is more likely happening, and why is raising the dose a problem?
Choose an answer, then check it.
Which findings best fit neuroleptic malignant syndrome rather than serotonin syndrome?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.